Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/heartjnl-2013-304274 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Percutaneous Mitral Valve-in-Ring Procedure in a Case of Severe Mitral Regurgitation Repaired with a Surgical Flexible Ring: A Step-by-Step Description.
Turk Kardiyol Dern Ars
January 2025
Department of Cardiology, Gülhane Faculty of Medicine, University of Health Sciences, Ankara, Türkiye.
Severe mitral regurgitation (MR) following surgical repair of the mitral valve poses a significant clinical challenge. Patients who have undergone surgery are typically at high risk for a second operation. This report details the case of a 54-year-old male who underwent aortic valve replacement and mitral valve repair using a 34-ring, 14 years prior.
View Article and Find Full Text PDFDebris Embolization to the Lung After a Bioprosthetic (Mitroflow®) Valve Fracture.
Catheter Cardiovasc Interv
January 2025
Complejo Hospitalario Universitario Insular Materno Infantil, Las Palmas, Spain.
This case report shows a valve in valve procedure in pulmonary position of a 19-year-old male with a repaired Tetralogy of Fallot. After initial correction, a Mitroflow 23 mm bioprosthetic valve was implanted in pulmonary position. Nine years later severe degeneration of the valve occurred.
View Article and Find Full Text PDFSeven-year outcomes after surgical aortic valve replacement with a stented bovine pericardial bioprosthesis in over 1100 patients: a prospective multicentre analysis.
Eur J Cardiothorac Surg
December 2024
Department of Cardiothoracic Surgery, Leiden University Medical Center, Leiden, The Netherlands.
Objectives: Safety, efficacy and durability are important considerations when selecting a bioprosthesis for aortic valve replacement (AVR). This study assessed 7-year clinical outcomes and haemodynamic performance of the Avalus bioprosthesis.
Methods: Patients indicated for surgical AVR were enrolled in this prospective, nonrandomized trial, conducted across 39 sites globally.
Transcatheter Aortic Valve in Failing Mechanical Aortic Valve.
JACC Cardiovasc Interv
October 2024
Interventional Cardiology Unit, Cardiology Department, Heart Sciences Institute, Clinical University Hospital, Valladolid, Spain. Electronic address:
Key Imaging Factors for Transcatheter Management of Tricuspid Regurgitation: Device and Patient Selection.
J Clin Med
October 2024
IRCCS Humanitas Research Hospital, Via Alessandro Manzoni, 56, Rozzano, 20089 Milano, Italy.
The growing awareness of tricuspid regurgitation (TR) and the fast-expanding array of devices aiming to percutaneously repair or replace the tricuspid valve have underscored the central role of multi-modality imaging in comprehensively assessing the anatomical and functional characteristics of TR. Accurate phenotyping of TR, the right heart, and pulmonary vasculature via echocardiography, computed tomography, and, occasionally, cardiovascular magnetic resonance and right heart catheterization is deemed crucial in choosing the most suitable treatment strategy for each patient and achieving procedural success. In the first part of the present review, key imaging factors for patient selection will be discussed.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!